Dallas, Texas, May 02, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling a variety of men’s health and wellness products in the area of erectile dysfunction (ED), hair growth and hormone replacement therapies, today announced that the Company received written notification from the Listing Qualification Department of The Nasdaq Stock Market LLC (“Nasdaq”) granting the Company’s request for a 180-day extension to regain compliance with Nasdaq’s minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2).

德克萨斯州达拉斯，2024年5月2日（环球通讯社）--Mangoceuticals，Inc.（纳斯达克股票代码：MGRX）（“MangoRx”或“公司”），一家专注于开发、营销和销售勃起功能障碍（ED）、毛发生长和激素替代疗法领域的各种男性健康和保健产品的公司，今天宣布，该公司收到了纳斯达克股票市场有限责任公司（“纳斯达克”）上市资格部门的书面通知，同意该公司要求延长180天，以重新符合纳斯达克上市规则5550（a）（2）规定的纳斯达克最低出价要求。

The Company now has until October 24, 2024 to meet the requirement. On the same date, Nasdaq provided notice to the Company that based on the Company’s April 25, 2024, Current Report on Form 8-K filing, Nasdaq has determined that the Company complies with Nasdaq Listing Rule 5550(b)(1) (the “Rule”) which requires companies listed on the Nasdaq Capital Market to maintain stockholders’ equity of at least $2,500,000.

该公司目前必须在2024年10月24日之前满足要求。同一天，纳斯达克向该公司发出通知，根据该公司2024年4月25日提交的8-K表格的最新报告，纳斯达克已确定该公司符合纳斯达克上市规则5550（b）（1）（“规则”）的规定，该规则要求在纳斯达克资本市场上市的公司维持至少250万美元的股东权益。

However, Nasdaq also advised that if the Company fails to evidence compliance with the Rule upon filing its next periodic report it may be subject to delisting. The Company was first notified by Nasdaq of its failure to maintain a minimum bid price of $1.00 per share for 30 consecutive trading days under Nasdaq Listing Rule 5550(a)(2) on November 1, 2023, and was given until April 29, 2024, to regain compliance.

然而，纳斯达克还表示，如果该公司在提交下一次定期报告时未能证明其符合规定，则可能会被摘牌。该公司于2023年11月1日首次收到纳斯达克通知，称其未能根据纳斯达克上市规则5550（a）（2）在连续30个交易日内维持每股1.00美元的最低出价，并被要求在2024年4月29日之前恢复合规。

At any time during the additional 180-day extension, if the bid price of the Company’s common stock closes at, or above, $1.00 per share for a minimum of ten consecutive business days, the Nasdaq staff will provide the Company with a written confirmation of compliance and the matter will be closed. The Company will continue to monitor the closing bid.

在额外的180天延期期间的任何时候，如果公司普通股的出价连续至少十个工作日以每股1.00美元或以上的价格收盘，纳斯达克员工将向公司提供书面合规确认书，该事项将被解决。该公司将继续监控收盘价。